AU Patent

AU2015271870A1 — An inhaler comprising a tiotropium-containing-composition

Assigned to Teva Branded Pharmaceutical Products R&D Inc · Expires 2016-01-21 · 10y expired

What this patent protects

This invention relates to a pressurised metered dose inhaler comprising a canister, wherein the canister contains a formulation comprising a tiotropium salt and an HFA propellant, wherein the inhaler is an inhalation-actuated inhaler. 7232128_1 (GHMatters) P96916.AU.1 JOSHUAF

USPTO Abstract

This invention relates to a pressurised metered dose inhaler comprising a canister, wherein the canister contains a formulation comprising a tiotropium salt and an HFA propellant, wherein the inhaler is an inhalation-actuated inhaler. 7232128_1 (GHMatters) P96916.AU.1 JOSHUAF

Drugs covered by this patent

Patent Metadata

Patent number
AU2015271870A1
Jurisdiction
AU
Classification
—
Expires
2016-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Teva Branded Pharmaceutical Products R&D Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.